Remove the noise, and the body remembers how to heal.
In an age when the wellness industry increasingly turns to chemical intervention and injectable optimization, Jay Dhaliwal built a $200 million company on a quieter premise: that the human body, given the right signals, already knows how to heal itself. Super Patch, developed over 16 years without a single outside investor, uses vibrotactile technology to communicate with the nervous system through the skin rather than overriding it with pharmaceuticals. Backed by peer-reviewed science and adopted by professional athletes across major sports leagues, the company stands as a rare counterargument to the assumption that progress in health must always mean more chemistry.
- A bootstrapped wellness company has reached $200M in revenue without venture capital, challenging the assumption that health tech requires aggressive outside funding to scale.
- Professional athletes across the NFL, NBA, NHL, and MLB are abandoning peptides and injectable biohacking in favor of drug-free patches, signaling a quiet revolt against chemical optimization culture.
- Sixteen peer-reviewed studies — six indexed in PubMed — give Super Patch scientific credibility that most wellness brands never achieve, separating it from the industry's chronic hype problem.
- The technology reframes the body not as a broken machine requiring chemical repair, but as a signal system that performs better when interference is removed rather than overridden.
- Super Patch's rise suggests the wellness industry may be approaching an inflection point where the next competitive frontier is not more sophisticated chemistry, but smarter biological communication.
Jay Dhaliwal spent 16 years and $25 million developing a technology he believed in before the market had a name for it. The result is Super Patch — small skin patches that deliver precise vibrational signals to the nervous system, with no drugs, no needles, and no outside investors. By 2025, the company had reached $200 million in revenue entirely through word-of-mouth, clinical credibility, and professional athlete adoption.
The core innovation, called Vibrotactile Trigger Technology, emerged from Dhaliwal's background in software engineering. He began to see the body less as a machine with broken parts and more as a system receiving corrupted signals. Rather than introducing chemicals into the bloodstream, the patches send vibrational "codes" designed to help the nervous system regulate itself more efficiently — supporting pain relief, sleep, and physical performance through a mechanism unlike anything in the traditional pharmaceutical toolkit.
The science has accumulated real weight. Sixteen peer-reviewed studies back the technology, with six indexed in PubMed and some results reaching statistical significance at p-values as low as 0.001. That clinical foundation matters in a wellness industry where extraordinary claims routinely outpace evidence.
Professional athletes across the NFL, NBA, NHL, and MLB have taken notice. These are competitors for whom marginal gains translate directly into career longevity and earnings — and they are turning away from hormone therapies and injectable biohacking in favor of patches that offer recovery benefits without dependency risk or chemical rebound.
Dhaliwal frames Super Patch as a "Third Option" between traditional pharmaceuticals and aggressive biohacking: not an override of the body's systems, but an amplification of what he calls its "Original Intelligence." In a health tech landscape obsessed with external fixes, Super Patch's capital-efficient rise suggests the next frontier may not be more chemistry — but learning to get out of the body's way.
Jay Dhaliwal built a $200 million company without taking a single dollar from investors. Super Patch, his creation, sells small patches that stick to skin and vibrate in precise patterns—no drugs, no needles, no pills. The patches work by sending targeted tactile signals through the skin to influence how the brain and body communicate with each other. After spending 16 years and $25 million developing the technology, Dhaliwal launched the company on the belief that the human body doesn't need to be chemically overridden. It needs to be listened to.
The core innovation is called Vibrotactile Trigger Technology, or VTT. Rather than introducing external chemicals into the bloodstream, the patches deliver vibrational "codes" designed to help the nervous system function more efficiently. The idea emerged from Dhaliwal's background in software engineering—he began to see the body less like a machine with broken parts and more like a system with corrupted signals. Remove the noise, he reasoned, and the body returns to its natural state of balance. The patches claim to support pain relief, better sleep, and physical performance, though the mechanism is fundamentally different from anything in the traditional pharmaceutical playbook.
The science behind Super Patch has accumulated real weight. Sixteen peer-reviewed studies back the technology, with six indexed in PubMed—the gold standard medical database. Some of those studies show statistical significance at p-values as low as 0.001, meaning the results are unlikely to be random chance. This clinical validation matters because it separates Super Patch from the wellness industry's usual hype. Dhaliwal didn't just make claims; he tested them.
The company's adoption tells its own story. Professional athletes across the NFL, NBA, NHL, and MLB now use Super Patch. These are competitors for whom marginal gains translate directly into millions of dollars and career longevity. They're turning away from peptides, hormone therapies, and other injectable optimization tools—the biohacking trend that has dominated elite performance culture for the past decade. What draws them to the patches is the absence of side effects, dependency risk, or the rebound problems that come with chemical interventions. A faster recovery without the chemical hangover is a compelling proposition when your livelihood depends on your body.
Dhaliwal frames Super Patch as the "Third Option" in a wellness landscape increasingly polarized between two extremes: traditional pharmaceuticals on one side and aggressive biohacking injectables on the other. Both approaches treat the body as something to be overridden or enhanced through external intervention. Super Patch instead positions itself as a tool for amplifying what the body already knows how to do. Dhaliwal calls this the "Original Intelligence" framework—the idea that the body has innate wisdom and that sometimes the most powerful intervention is simply removing interference.
The business model itself is unusual. In an era when health tech companies chase venture capital aggressively, Super Patch grew entirely bootstrapped. No outside investors, no dilution of ownership, no pressure to chase growth at the expense of product integrity. The company reached $200 million in revenue in 2025 through word-of-mouth adoption, clinical credibility, and professional athlete endorsement. This capital-efficient path suggests something about the market: there's genuine demand for alternatives to pills and injections, and that demand is strong enough to fund a company without venture backing.
What Super Patch represents is a shift in how we think about health technology. The longevity and optimization industries have become increasingly obsessed with external fixes—better supplements, newer peptides, more sophisticated hormonal manipulation. Super Patch's success suggests that the next frontier might not be more chemistry but smarter communication. The body is already sophisticated. Sometimes it just needs the noise cleared away.
Citações Notáveis
We're not trying to replace what the body does naturally. We're removing the neural noise so the body can return to its default setting of balance and resilience.— Jay Dhaliwal, Super Patch CEO
A Conversa do Hearth Outra perspectiva sobre a história
Why does a patch that vibrates matter more than a pill that delivers an actual drug?
Because the body isn't broken hardware. It's a communication system. A drug overrides the system. A vibration pattern helps the system work better on its own terms.
But how do you know the vibration is actually doing anything? Couldn't it be placebo?
That's why there are 16 peer-reviewed studies. Six are in PubMed. The p-values go down to 0.001. Professional athletes don't use placebos when their contracts depend on real results.
Why would an NFL player choose a patch over a peptide injection?
No side effects. No rebound crash. No dependency. A peptide works fast but leaves you chasing the next dose. A patch works with what your body already knows how to do.
Dhaliwal spent 16 years on this. Why so long?
Because he wasn't trying to invent a drug. He was trying to decode how the nervous system communicates through the skin. That's not a pharmaceutical problem. It's a signal problem. Those take time.
What does "Original Intelligence" actually mean?
It means your body has its own wisdom. Most health tech tries to override that. Super Patch tries to amplify it. Remove the noise, and the body remembers how to heal.
Is this going to replace pills?
Not all of them. But for performance, recovery, and pain—the things athletes care about—it's already replacing injections. That's the wedge.